Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virotest Inc
Original Assignee
VIROTECHNOLOGY Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VIROTECHNOLOGY IncfiledCriticalVIROTECHNOLOGY Inc
Publication of AU2980189ApublicationCriticalpatent/AU2980189A/en
Application grantedgrantedCritical
Publication of AU623878B2publicationCriticalpatent/AU623878B2/en
Assigned to VIROTEST, INC.reassignmentVIROTEST, INC.Alteration of Name(s) in Register under S187Assignors: VIROTECHNOLOGY, INC.
Composition comprenant des antigenes conjugues a une activite enzymatique, et destinee aux necessaires a usage prive et epidemiologique de diagnostic immunologique, notamment de la maladie de chagas, et procede de preparation de ladite composition
DOSAGE IMMUNO-ENZYMATIQUE POUR DIAGNOSTIQUER L'ANEMIE INFECTIEUSE EQUINE AU MOYEN DE LA PROTEINE RECOMBINANTE (gp90) DERIVEE DU VIRUS DE L'ANEMIE INFECTIEUSE EQUINE
DOSAGE IMMUNO-ENZYMATIQUE POUR DIAGNOSTIQUER L'ANEMIE INFECTIEUSE EQUINE AU MOYEN DE LA PROTEINE RECOMBINANTE (gp90) DERIVEE DU VIRUS DE L'ANEMIE INFECTIEUSE EQUINE